Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET.
Holzschuh JC, Mix M, Freitag MT, Hölscher T, Braune A, Kotzerke J, Vrachimis A, Doolan P, Ilhan H, Marinescu IM, Spohn SKB, Fechter T, Kuhn D, Gratzke C, Grosu R, Grosu AL, Zamboglou C. Holzschuh JC, et al. Among authors: spohn skb. Radiat Oncol. 2024 Aug 7;19(1):106. doi: 10.1186/s13014-024-02491-w. Radiat Oncol. 2024. PMID: 39113123 Free PMC article.
[68Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - Implications for focal radiotherapy planning in primary prostate cancer.
Bettermann AS, Zamboglou C, Kiefer S, Jilg CA, Spohn S, Kranz-Rudolph J, Fassbender TF, Bronsert P, Nicolay NH, Gratzke C, Bock M, Ruf J, Benndorf M, Grosu AL. Bettermann AS, et al. Radiother Oncol. 2019 Dec;141:214-219. doi: 10.1016/j.radonc.2019.07.005. Epub 2019 Aug 17. Radiother Oncol. 2019. PMID: 31431366
Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients.
Spohn S, Jaegle C, Fassbender TF, Sprave T, Gkika E, Nicolay NH, Bock M, Ruf J, Benndorf M, Gratzke C, Grosu AL, Zamboglou C. Spohn S, et al. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2796-2803. doi: 10.1007/s00259-020-04827-6. Epub 2020 Apr 28. Eur J Nucl Med Mol Imaging. 2020. PMID: 32342192 Free PMC article.
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
Kostyszyn D, Fechter T, Bartl N, Grosu AL, Gratzke C, Sigle A, Mix M, Ruf J, Fassbender TF, Kiefer S, Bettermann AS, Nicolay NH, Spohn S, Kramer MU, Bronsert P, Guo H, Qiu X, Wang F, Henkenberens C, Werner RA, Baltas D, Meyer PT, Derlin T, Chen M, Zamboglou C. Kostyszyn D, et al. J Nucl Med. 2021 Jun 1;62(6):823-828. doi: 10.2967/jnumed.120.254623. Epub 2020 Oct 30. J Nucl Med. 2021. PMID: 33127624 Free PMC article.
Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis.
Schmidt Hegemann NS, Rogowski P, Eze C, Schäfer C, Stief C, Lang S, Spohn S, Steffens R, Li M, Gratzke C, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Ganswindt U, Buchner A, Grosu AL, Belka C, Meyer PT, Kirste S, Zamboglou C. Schmidt Hegemann NS, et al. Cancers (Basel). 2020 Nov 16;12(11):3395. doi: 10.3390/cancers12113395. Cancers (Basel). 2020. PMID: 33207785 Free PMC article.
Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer.
Zamboglou C, Bettermann AS, Gratzke C, Mix M, Ruf J, Kiefer S, Jilg CA, Benndorf M, Spohn S, Fassbender TF, Bronsert P, Chen M, Guo H, Wang F, Qiu X, Grosu AL. Zamboglou C, et al. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1987-1997. doi: 10.1007/s00259-020-05111-3. Epub 2020 Nov 18. Eur J Nucl Med Mol Imaging. 2021. PMID: 33210239 Free PMC article.
Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI-A Correlation Study With Whole Mount Histopathological Information as Reference.
Kramer M, Spohn SKB, Kiefer S, Ceci L, Sigle A, Oerther B, Schultze-Seemann W, Gratzke C, Bock M, Bamberg F, Grosu AL, Benndorf M, Zamboglou C. Kramer M, et al. Among authors: spohn skb. Front Oncol. 2020 Nov 23;10:596756. doi: 10.3389/fonc.2020.596756. eCollection 2020. Front Oncol. 2020. PMID: 33330088 Free PMC article.
Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference.
Spohn SKB, Kramer M, Kiefer S, Bronsert P, Sigle A, Schultze-Seemann W, Jilg CA, Sprave T, Ceci L, Fassbender TF, Nicolay NH, Ruf J, Grosu AL, Zamboglou C. Spohn SKB, et al. Front Oncol. 2020 Dec 7;10:600690. doi: 10.3389/fonc.2020.600690. eCollection 2020. Front Oncol. 2020. PMID: 33365271 Free PMC article.
The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer.
Zamboglou C, Kramer M, Kiefer S, Bronsert P, Ceci L, Sigle A, Schultze-Seemann W, Jilg CA, Sprave T, Fassbender TF, Nicolay NH, Ruf J, Benndorf M, Grosu AL, Spohn SKB. Zamboglou C, et al. Among authors: spohn skb. Sci Rep. 2021 Mar 12;11(1):5836. doi: 10.1038/s41598-021-85028-5. Sci Rep. 2021. PMID: 33712662 Free PMC article.
51 results